Showing results (131-140 of 216) with videos related to
Sort By:
Pageof 22
Annals of Burns and Fire Disasters|March 12, 2021
Pre-Hospital Care Of Patients With Severe Burns In Germany: A Review Of 29 Years Of ExperienceJ L Schiefer, W Perbix, D Grigutsch, et al.Antimicrobial Agents and Chemotherapy|August 1, 1981
Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.Journal of Clinical Microbiology|October 1, 1991
Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacinP C Fuchs, A L Barry, C Baker, et al.American Journal of Clinical Pathology|November 1, 1986
The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactamR N Jones, A L Barry, C Thornsberry, et al.Journal of Clinical Microbiology|August 1, 1992
Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinationsP C Fuchs, A L Barry, C N Baker, et al.Annals of Burns and Fire Disasters|May 31, 2021
Does Platelet-Rich Fibrin Enhance Healing Of Burn Wounds? Our First Experiences And Main PitfallsA Schulz, J L Schiefer, P C Fuchs, et al.Antimicrobial Agents and Chemotherapy|May 23, 2002
Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methodsA L Barry, M A Pfaller, R P Rennie, et al.Burns : Journal of the International Society for Burn Injuries|March 26, 2017
Our initial learning curve in the enzymatic debridement of severely burned hands-Management and pit falls of initial treatments and our development of a post debridement wound treatment algorithmA Schulz, W Perbix, Y Shoham, et al.Diagnostic Microbiology and Infectious Disease|November 1, 2001
Cefditoren in vitro activity and spectrum: a review of international studies using reference methodsR N Jones, M A Pfaller, M R Jacobs, et al.Antimicrobial Agents and Chemotherapy|April 1, 1991
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesP C Fuchs, A L Barry, M A Pfaller, et al.Pageof 22